Emerging disease information at your fingertips.
Provider
Resources
Recent Articles
→-
Health Advisory: 2024–2025 Respiratory Illness Season Vaccine Recommendations
ACTIONS REQUESTED BE AWARE that the CDC recommends everyone 6 months or older get 2024–2025 COVID-19 and flu vaccine. Co-administration of COVID-19, flu, and RSV vaccines is safe. BE AWARE that the CDC expects supplies of nirsevimab (Beyfortus) RSV monoclonal antibody for infants and young children to be adequate for the 2024–2025 season. REMIND patients that vaccination is one…
-
Kitsap Respiratory Illness Report: Aug. 18 to Sept. 14
In the week ending September 14, local indicators for COVID-19 remained at elevated levels, which have more or less remained steady since the end of June 2024. Local indicators for influenza and respiratory syncytial virus (RSV) remained very low. 1.8% of emergency department (ED) visits were attributable to COVID-19, fewer than 10 visits were attributable to either influenza…
-
Health Advisory: 2024-2025 COVID-19 vaccines approved
ACTIONS REQUESTED BE AWARE that updated (2024–2025) COVID-19 vaccines have been approved and authorized by the FDA. The new formulations provide better protection against currently circulating COVID-19 variants. For more information, see: DISCONTINUE USE of the 2023–2024 Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines. These formulations are no longer authorized by the FDA. BE AWARE that there are two types…
Providers &
Long Term Care
The resources you need, from treatment guidelines to the newest information on emerging conditions.